Advancing antibody drug conjugates in gastrointestinal cancers.
Saved in:
| Title: | Advancing antibody drug conjugates in gastrointestinal cancers. |
|---|---|
| Authors: | Cassier PA; Département de Cancérologie Médicale, Centre Léon Bérard, Lyon, France. philippe.cassier@lyon.unicancer.fr.; CRCL, INSERM 1052/CNRS 5286, Molecular regulation of Immunity in Cancer, Lyon, France. philippe.cassier@lyon.unicancer.fr., Izarn F; Département de Cancérologie Médicale, Centre Léon Bérard, Lyon, France., Dumontet C; University of Lyon/Hospices Civils de Lyon, Lyon, France.; CRCL, INSERM 1052/CNRS 5286, Onco-pharmacology, Lyon, France., Coutzac C; Département de Cancérologie Médicale, Centre Léon Bérard, Lyon, France.; CRCL, INSERM 1052/CNRS 5286, Gastroenterology and Technologies for Health, Lyon, France. |
| Source: | British journal of cancer [Br J Cancer] 2026 Jul 23. Date of Electronic Publication: 2026 Jul 23. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1532-1827 |
|---|---|
| DOI: | 10.1038/s41416-026-03510-1 |
